Observing the effects of kidney cancer surgery on patients
2007 - Rene: Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Radical Nefrectomy/Tumorectomy Surgery
This study looks at how kidney cancer surgery affects patients over time to see how it impacts their quality of life and chances of relapse.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, MI) |
| Trial ID | NCT06147349 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect clinical data from patients who have undergone radical or partial nephrectomy for kidney cancer. Participants will be followed for approximately 10 years, with regular visits and questionnaires to assess their quality of life and monitor for potential relapses. Data will be gathered through an electronic case report form, ensuring adherence to strict privacy and good clinical practice standards. The study seeks to enhance scientific understanding of renal cancer and improve future treatment strategies.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with kidney cancer who are scheduled for surgical intervention.
Not a fit: Patients under 18 years old or those without a kidney cancer diagnosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with kidney cancer.
How similar studies have performed: Other observational studies have shown success in understanding the long-term effects of cancer surgeries, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Kidney cancer diagnosis * Indication to cancer removal through surgery * Ability to read and sign the informed consent Exclusion Criteria: * Age \< 18 years * Absence of kidney cancer * Inability to read and sign the informed consent
Where this trial is running
Milan, MI
- IRCCS Ospedale San Raffaele — Milan, Mi, Italy (Recruiting)
Study contacts
- Principal investigator: Francesco Montorsi, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Francesco Montorsi, MD.
- Email: montorsi.francesco@hsr.it
- Phone: 02 2643 7286
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.